NL7611085A - Werkwijze voor de bereiding van neuroleptisch werkende stoffen en van preparaten die ze be- vatten. - Google Patents

Werkwijze voor de bereiding van neuroleptisch werkende stoffen en van preparaten die ze be- vatten.

Info

Publication number
NL7611085A
NL7611085A NL7611085A NL7611085A NL7611085A NL 7611085 A NL7611085 A NL 7611085A NL 7611085 A NL7611085 A NL 7611085A NL 7611085 A NL7611085 A NL 7611085A NL 7611085 A NL7611085 A NL 7611085A
Authority
NL
Netherlands
Prior art keywords
neuroleptic
preparation
preparations containing
acting substances
substances
Prior art date
Application number
NL7611085A
Other languages
English (en)
Dutch (nl)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NL7611085A publication Critical patent/NL7611085A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NL7611085A 1975-10-08 1976-10-07 Werkwijze voor de bereiding van neuroleptisch werkende stoffen en van preparaten die ze be- vatten. NL7611085A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62072775A 1975-10-08 1975-10-08
US05/713,309 US4035369A (en) 1975-10-08 1976-08-10 1-Benzazolylalkyl-4-substituted-piperidines

Publications (1)

Publication Number Publication Date
NL7611085A true NL7611085A (nl) 1977-04-13

Family

ID=27088773

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7611085A NL7611085A (nl) 1975-10-08 1976-10-07 Werkwijze voor de bereiding van neuroleptisch werkende stoffen en van preparaten die ze be- vatten.

Country Status (31)

Country Link
US (1) US4035369A (xx)
JP (1) JPS5246082A (xx)
AT (1) AT365185B (xx)
AU (1) AU511834B2 (xx)
BG (1) BG27542A3 (xx)
CA (1) CA1085853A (xx)
CH (1) CH630915A5 (xx)
CS (1) CS225101B2 (xx)
DE (1) DE2645125A1 (xx)
DK (1) DK151801C (xx)
EG (1) EG12969A (xx)
ES (1) ES452200A1 (xx)
FI (1) FI63228C (xx)
FR (1) FR2346009A1 (xx)
GB (1) GB1532546A (xx)
GR (1) GR61672B (xx)
HU (1) HU174927B (xx)
IE (1) IE43951B1 (xx)
IL (1) IL50631A (xx)
IT (1) IT1069293B (xx)
LU (1) LU75954A1 (xx)
NL (1) NL7611085A (xx)
NO (1) NO144926C (xx)
NZ (1) NZ182134A (xx)
PH (1) PH15417A (xx)
PL (1) PL106815B1 (xx)
PT (1) PT65688B (xx)
RO (1) RO69904A (xx)
SE (1) SE417610B (xx)
SU (1) SU663306A3 (xx)
YU (1) YU39976B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
EP0034116A3 (en) * 1980-02-11 1981-09-02 Berlex Laboratories, Inc. N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2702214B1 (fr) * 1993-03-05 1995-04-14 Adir Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
ATE247114T1 (de) 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
EP2064227A2 (en) * 2006-09-19 2009-06-03 Cipla Ltd. Processes for the preparation of ciclesonide and its crystal form
CN101759693B (zh) * 2008-12-23 2011-09-14 江苏恩华药业股份有限公司 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用
CA3211341A1 (en) * 2021-03-19 2022-09-22 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (xx) * 1962-06-13
US3225052A (en) * 1964-05-06 1965-12-21 Janssen Pharmaceutica Nv Benzimidazolinyl piperidine derivatives
FR1573739A (xx) 1968-07-26 1969-07-04
US3635982A (en) * 1969-04-08 1972-01-18 American Home Prod Amino-substituted-quinoxalinyloxazolidines and -oxazines

Also Published As

Publication number Publication date
FR2346009B1 (xx) 1978-12-22
CA1085853A (en) 1980-09-16
AT365185B (de) 1981-12-28
IL50631A (en) 1980-02-29
IL50631A0 (en) 1976-12-31
DE2645125C2 (xx) 1988-11-24
JPS5246082A (en) 1977-04-12
HU174927B (hu) 1980-04-28
FR2346009A1 (fr) 1977-10-28
SE7611137L (sv) 1977-04-09
FI63228B (fi) 1983-01-31
US4035369A (en) 1977-07-12
FI762865A (xx) 1977-04-09
CS225101B2 (en) 1984-02-13
DE2645125A1 (de) 1977-04-21
NO144926C (no) 1981-12-09
PH15417A (en) 1983-01-07
DK452076A (da) 1977-04-09
SU663306A3 (ru) 1979-05-15
BG27542A3 (bg) 1979-11-12
ES452200A1 (es) 1978-01-16
YU248076A (en) 1983-01-21
IT1069293B (it) 1985-03-25
PL106815B1 (pl) 1980-01-31
AU1807876A (en) 1978-04-06
EG12969A (en) 1981-03-31
LU75954A1 (xx) 1977-05-09
PT65688B (en) 1978-04-02
GB1532546A (en) 1978-11-15
YU39976B (en) 1985-06-30
JPS6215553B2 (xx) 1987-04-08
GR61672B (en) 1978-12-05
DK151801C (da) 1988-06-06
NO763424L (xx) 1977-04-13
PT65688A (en) 1976-11-01
SE417610B (sv) 1981-03-30
ATA745276A (de) 1981-05-15
DK151801B (da) 1988-01-04
PL192890A1 (pl) 1978-03-28
RO69904A (fr) 1980-08-15
AU511834B2 (en) 1980-09-11
CH630915A5 (de) 1982-07-15
FI63228C (fi) 1983-05-10
IE43951B1 (en) 1981-07-01
NZ182134A (en) 1979-01-11
IE43951L (en) 1977-04-08
NO144926B (no) 1981-08-31

Similar Documents

Publication Publication Date Title
NL7610063A (nl) Werkwijze voor de bereiding van n-(beta)-gesubsti- tueerde benzilzuur-n-alkyl-nortropine-esters en werkwijze voor de bereiding van preparaten die ze bevatten.
NL160311C (nl) Werkwijze voor de bereiding van hardbare organopolysiloxan- materialen.
NL7604583A (nl) Werkwijze voor de bereiding van imidazool-deri- vaten en preparaten die ze bevatten.
NL7512848A (nl) Werkwijze voor de bereiding van contraceptieve stoffen en preparaten.
NL7611085A (nl) Werkwijze voor de bereiding van neuroleptisch werkende stoffen en van preparaten die ze be- vatten.
NL165463C (nl) Werkwijze voor de bereiding van fungicide imidazolyl- -derivaten en voor de bereiding van preparaten die ze bevatten.
NL7512902A (nl) Werkwijze voor de bereiding van herbicide stoffen en van preparaten die ze bevatten.
NL7707684A (nl) Werkwijze voor de bereiding van hypolypemische stoffen en preparaten die ze bevatten.
NL7514255A (nl) Werkwijze voor de bereiding van piperidylindolen en farmaceutische preparaten die ze bevatten.
NL7513230A (nl) Werkwijze voor de bereiding van farmaceutische tabletten.
NL7612239A (nl) Werkwijze ter bereiding van derivaten van dauno- rubicine alsmede preparaten die deze derivaten bevatten.
NL169739C (nl) Werkwijze voor de bereiding van prostaglandines en werkwijze voor de bereiding van preparaten die ze bevatten.
NL171270C (nl) Werkwijze voor de bereiding van 1,2,3,4,6,7,12,12a-octahydropyrazinoŸ2',1':6,1Ÿ pyridoŸ3,4-bŸindolen en werkwijze voor de bereiding van preparaten die ze bevatten.
NL184111C (nl) Werkwijze voor het bereiden van androstenonen en van farmaceutische preparaten welke deze bevatten.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL7611254A (nl) Werkwijze voor de bereiding van nieuw cyclo- hexylfenyl-derivaten en werkwijze voor de be- reiding van preparaten die ze bevatten.
NL7700899A (nl) Werkwijze voor de bereiding van coccidiostatica en van preparaten die ze bevatten.
NL7512847A (nl) Werkwijze voor de bereiding van contraceptieve stoffen en preparaten.
NL166015C (nl) Werkwijze voor de bereiding van prostaglandien-analoga en voor de bereiding van preparaten die ze bevatten.
NL7714205A (nl) Werkwijze ter bereiding van 5-fluoruracilderi- vaten en farmaceutische preparaten die deze derivaten bevatten.
NL7607693A (nl) Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten.
NL186699C (nl) Kanamycine-derivaten, werkwijze voor de bereiding daarvan, werkwijze voor de bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL7608903A (nl) Werkwijze voor de bereiding van guanidine- -derivaten en van preparaten die ze bevatten.
NL148319B (nl) Werkwijze voor de bereiding van herbicide verbindingen en preparaten die ze bevatten.
NL7605385A (nl) Werkwijze voor de bereiding van 3-nitropyrazool- -derivaten en van preparaten die ze bevatten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed